INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Appropriations History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹37 Cr | ₹31 Cr | ₹22 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Appropriations of INDO US BIOTECH ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹11 Cr |
How is Appropriations of INDO US BIOTECH Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 20.39 | |
| Mar2024 | ₹31 Cr | 36.92 | |
| Mar2023 | ₹22 Cr | 35.66 | |
| Mar2022 | ₹16 Cr | 46.60 | |
| Mar2021 | ₹11 Cr | - | |
Compare Appropriations of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹211.1 Cr | 2.5% | 4.9% | -39.3% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,472.1 Cr | 0.3% | 9.1% | -20.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,960.0 Cr | 2.5% | 21.8% | -35.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,232.1 Cr | 4.4% | 30.5% | -7.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,033.1 Cr | -3.6% | 46.1% | -27.8% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹450.5 Cr | 0.6% | 16.9% | 6.4% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 2.5% |
4.9% |
-39.3% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses